Avanir Pharmaceuticals Inc
Avanir Pharmaceuticals Inc is a US-based biopharmaceutical company focused on acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders.
The company's focus is to bring innovative medicines to patients with central nervous system disorders of high unmet medical need.
It is a subsidiary of Otsuka America Inc, a holding company established in the US in 1989.
Latest Avanir Pharmaceuticals Inc News & Features
20 June 2024
30 May 2024
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze